SecBot SecBot
DEFA14A ·Filed Jun 26, 2026

VXRT

Vaxart, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago SEC0001213900-26-072727
Proxy solicitation materials
Actionable Insight • Neutral

The proxy contest continues with management actively soliciting votes. The outcome likely favors the board given the dissident's small ownership (~0.7%) and lack of experience. No immediate trading catalyst; monitor the annual meeting date for vote results.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.5700
T+0 close · Jun 26, 2026 · via day close
Latest settled
−14.04%
T+60 · $0.4900
Vs SPY
−17.08%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 29 $0.5700entry
  2. T+1 · 5mo ago +5.26%α +4.48% · $0.6000
  3. T+5 · 4mo ago +10.44%α +9.05% · $0.6295
  4. T+20 · 4mo ago −21.04%α −20.78% · $0.4501
  5. T+60 · 8w ago −14.04%α −17.08% · $0.4900

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vaxart filed definitive additional proxy materials (DEFA14A) urging shareholders to vote FOR all six board nominees and WITHHOLD on the three dissident nominees from stockholder Daniel P. Houle. The filing contains social media posts reiterating management's argument that the dissidents lack relevant clinical-stage biotech experience. This is a routine solicitation update in the ongoing proxy contest with no new material information.

Key Financial Metrics

Vote
director election
Seats Contested
3

Key Facts

  • Vaxart filed DEFA14A urging shareholders to vote FOR all 6 board nominees and WITHHOLD on dissident nominees.
  • Dissident slate from stockholder Daniel P. Houle (3 nominees) is opposed by management.
  • Management argues dissidents lack relevant clinical-stage biotech experience and are undermining resolution efforts.
  • Filing includes social media posts (LinkedIn, X) directing shareholders to vote.vaxart.com.

Financial Impact

No financial figures disclosed; proxy contest costs are not quantified.

Risk Factors

  • Dissident could gain seats if shareholder dissatisfaction is higher than expected.
  • Proxy contest may distract management from pipeline progress.

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001213900-26-072727
Document: 0001213900-26-072727-index-headers.html0001213900-26-072727
Document: 0001213900-26-072727-index.html0001213900-26-072727
Document: 0001213900-26-072727.txt0001213900-26-072727

Track record

23 reports on VXRT

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +37.66% at T+60 after the May 1, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $0.3700 Now $0.3600 +2.70% settles Feb 4
  2. Oct 19, 202628d ago 8-K Neutral 3/10 Entry $0.4900 Now $0.3600 −26.53% settles Jan 15
  3. Jul 28, 202615w ago 8-K Neutral 2/10 Entry $0.4800 to $0.4900 Now $0.3600 −25.00% ▲ +2.08% −2.53% vs SPY
  4. Jul 7, 202618w ago 8-K Neutral 4/10 Entry $0.5500 to $0.4500 Now $0.3600 −34.55% ▼ −18.18% −21.27% vs SPY
  5. Jul 6, 202619w ago DEFA14A Neutral 5/10 Entry $0.6200 to $0.4540 Now $0.3600 −41.94% ▼ −26.77% −28.93% vs SPY
  6. Jul 2, 202619w ago DEFA14A Bullish 5/10 Entry $0.6400 to $0.4500 Now $0.3600 −43.75% ▼ −29.69% −33.51% vs SPY
  7. Jul 2, 202619w ago 8-K Neutral 4/10 Entry $0.6400 to $0.4520 Now $0.3600 −43.75% ▼ −29.38% −32.80% vs SPY
  8. Jun 26, 202620w ago DEFA14A Neutral 4/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
  9. Jun 26, 202620w ago DEFA14A Neutral 3/10 Viewing Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
  10. Jun 26, 202620w ago 8-K Mixed 5/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 26, 2026